Here is the extracted table of clinical events and timestamps:

born | -8760
caesarean section | -8760
birth weight 2100 g | -8760
birth length 48 cm | -8760
Apgar scale 8 points | -8760
prominent forehead | -8760
relative macrocephaly | -8760
limb asymmetry | -8760
5th finger clinodactyly | -8760
2/3 toe syndactyly | -8760
genetic examination | -489
hypomethylation of the 11p15 region | -489
diagnosis of SRS | -489
delayed motor development | -336
walked independently | -336
hepatic dysfunction | -420
increased AlAT | -420
increased AspAT | -420
increased creatine kinase | -420
diagnosis of DMD | -336
genetic test | -336
mutation of the maternal DMD gene | -336
corticosteroids treatment | -192
prednisone treatment | -192
deflazacort treatment | -96
G-CSF treatment | -72
sepsis | -72
hypoglycaemia | -72
neurological symptoms | -72
glucose level 14 mg/dl | -72
urological care | -72
hypospadias | -72
cardiological diagnostics | -12
sinus tachycardia | -12
heart murmur | -12
propranolol treatment | -12
growth hormone deficiency | 0
rhGH treatment | 0
height 115.9 cm | 0
weight 19.9 kg | 0
BMI 14.8 kg/m2 | 0
target height 182.5 cm | 0
height velocity 4.3 cm/year | 0
glucose and insulin levels | 0
IGF-1 and IGFBP-3 concentrations | 0
MRI of the hypothalamic-pituitary region | 0
transparent septum cyst | 0
rhGH therapy started | 0
height velocity increased | 12
IGF-1 level increased | 12
BMI increased | 12
glucose metabolism worsened | 12
insulin resistance | 12
HbA1c elevated | 12
6MWT distance decreased | 12
abnormal gait | 12
rhGH dose reduced | 12
behavioural treatment | 12
lifestyle modification | 12
rhGH therapy discontinued | 18
densitometry performed | 18
body mass composition examined | 18
bone density test | 18
Z-score -2.2 | 18